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Abstract
Background: Since 2000, substantial increases in syphilis in men who have sex with men (MSM) have been
reported in many cities. Condomless anal sex (CAS) is one of the factors, along with drugs for sex and sex in group.
This study identified factors and clinical manifestations as well as Treponema pallidum (T.pallidum) strains that could
be related to early syphilis in Barcelona.
Methods: This prospective study was conducted in a sexually transmitted infections unit in 2015. Epidemiological,
behavioral, clinical and microbiological variables were collected in a structured form. Univariate and multivariate
statistical analyses were performed focusing on HIV-positive patients.
Results: Overall, 274 cases were classified as having early syphilis (27.5% primary, 51.3% secondary, and 21.2% early
latent syphilis). In all, 94% of participants were MSM and 36.3% were HIV-positive. The median number of sexual
contacts in the last 12 months was 10; 72.5% practiced CAS, 50.6% had sex in group, and 54.7% consumed drugs.
HIV-positive cases had more anonymous sex contacts (p = 0.041), CAS (p = 0.002), sex in group (p < 0.001) and drugs
for sex (p < 0.001). In the multivariate analysis, previous syphilis (adjusted odds ratio [aOR] 4.81 [2.88–8.15]), previous
Neisseria gonorrhoeae infection (aOR 3.8 [2.28–6.43]), and serosorting (aOR 20.4 [7.99–60.96]) were associated with
having syphilis. Clinically, multiple chancres were present in 31% of cases with no differences on serostatus, but
anal chancre was most common in HIV-positive patients (p = 0.049). Molecular typing did not conclusively explain
clinical presentation in relation to specific T.pallidum strains.
Conclusion: Control of syphilis remains a challenge. Similar to prior studies, HIV-positive patients were found to
engage more often in sexual behaviors associated with syphilis than HIV-negative patients. Clinical manifestations
were rather similar in both groups, although anal chancre was most common in HIV-positive patients. Various strain
types of syphilis were found, but no clinical associations were identified.
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Background
Since 2000, substantial increases in cases of early syphilis
have been reported in metropolitan areas of Western
countries. These increases have been described particu-
larly among men who have sex with men (MSM). In
Europe, there were 28,701 cases of early syphilis re-
ported in 2015, yielding a rate of 6.0 per 100,000
inhabitants [1]. Similarly, an increase has been described
in our setting in Catalonia (Spain): in 2014, the rate of
early syphilis was 12.4 per 100,000 inhabitants, a 231%
increase over the figures for 2005 observed mainly in
MSM [2].
One of the most important factors affecting syphilis
transmission is the practice of condomless anal sex
(CAS) [3]. Other factors, such as drug consumption,
internet use for sexual contacts, and sex in group have
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also been reported [4]. In some studies, these risk fac-
tors are directly related to syphilis, whereas, other
studies have found, indirect links with CAS [5, 6]. HIV
coinfection has been demonstrated to be strongly
associated with syphilis [3, 7].Clinically, some differ-
ences have been described between HIV-positive and
HIV-negative patients, for instance, in atypical
manifestations, such as multiple chancres in primary
syphilis [8] or the persistence of chancres in secondary
syphilis [9] in HIV-positive patients.
Molecular typing of Treponema pallidum subspe-
cies pallidum (T. pallidum) has been used for
different purposes [10–12]. Epidemiologically, use of
the technique has identified a wide distribution of
strain types depending on geographic location, with
14d/g being the most common in Europe [13, 14].
Some strains have been associated with clinical out-
comes such as neurosyphilis in rabbits, although this
has not been shown in humans [10].
The aim of this study was to provide updated
information on syphilis in Barcelona by identifying
factors associated with early syphilis and occurrence
of these factors, focusing on HIV-positive patients.
An additional aim was to describe the clinical char-
acteristics of syphilis, exploring the role of specific
strain types of T. pallidum. Altogether, the study
was intended to gain an overview of the syphilis epi-
demic that affects MSM in particular.
Methods
This prospective study was conducted in the Sexually
Transmitted Infections Unit Vall d’Hebron-Drassanes
in Barcelona, Spain (STIUVD). The STIUVD is the
main referral sexually transmitted infections (STIs) in
Catalonia and is located in the downtown area of Bar-
celona. It provides care to patients for a total of
25000 visits per year (60% MSM) and reported around
50% of all syphilis cases seen in Barcelona during the
study period.
All patients aged 18 years or older with early syph-
ilis who came between 15 January and 15 October 15,
2015 were eligible to participate in the study. Syphilis
diagnosis and management were based on the Euro-
pean syphilis guidelines [15]. Primary syphilis was de-
fined as a typical ulcer (chancre) and/or a positive test
using dark-field microscopy or as polymerase chain
reaction (PCR) detection of T. pallidum and/or a
positive serological test for syphilis. Secondary syph-
ilis was defined based on typical clinical symptoms
with positive treponemal and non-treponemal tests.
Early latent syphilis was defined as positive serological
treponemal and non-treponemal tests with no clinical
evidence of infection, with a previous negative syphilis
serology, or a four-fold increase in the titer of a non-
treponemal test (i.e. two dilutions) within the past 12
months. Cured syphilis was defined as a four-fold de-
cline in the titer of a non-treponemal test within 1
year of treatment.
Behavioral variables
Participants completed a self-administered question-
naire of demographic and sexual behavior information
from the previous 12 months. Variables included how
they met their partners and practices such as sex in
group, drugs for sex, use of condoms, serosorting (sex
between partners with same HIV status) and seroposi-
tioning (adapting sexual practices according to one’s
HIV status). The self-administered questionnaire was
based on the European MSM Internet Survey (EMIS)
[16], which had been previously modified, piloted, and
revised. An adapted version of this questionnaire was
used for heterosexual participants. Drugs for sex was
defined as substance use 2 h before or during inter-
course; chemsex was defined as the use of crystal
methamphetamine, gammahydroxybutrate (GHB), and/
or mephedrone before or during sexual sessions; and
poly drug use was defined as the consumption of three
or more drugs, excluding alcohol or cannabis. CAS was
defined as the absence of systematic use of a condom,
even if used occasionally. Clinical and microbiological
variables were completed by the attending physicians.
Information on pre-exposure prophylaxis against (PrEP)
HIV was not collected because it was not readily available
at that time.
If patients had more than 1 episode of syphilis during
the study period, the epidemiological and behavioral
data were analyzed only once. To determine the risk fac-
tors for the acquisition of syphilis according to HIV
status, HIV-positive patients were defined as patients
who knew that they were HIV-positive at syphilis diag-
nosis, excluding patients whose diagnoses of HIV and
syphilis infection coincided. However, in the clinical ana-
lysis, the latter (patients with coincident diagnoses) were
included in the HIV coinfection group analysis because
the clinical manifestations and course of syphilis could
be influenced by HIV.
Microbiological tests
All patients were tested for syphilis following a reverse
algorithm sequence screening algorithm. Initial screen-
ing consisted of a specific test for antibodies against T.
pallidum with any positive results a subsequently
confirmed by a non-treponemal test and another trepo-
nemal test. The tests used were the treponemal enzyme
immunoassay (EIA, Siemens Healthcare Diagnostics,
Germany), rapid plasma regain (RPR) test (Biokit, Spain),
T. pallidum particle hemagglutination assay (TPHA,
Biokit, Spain), and indirect immunofluorescence assay
Arando et al. BMC Infectious Diseases          (2019) 19:727 Page 2 of 9
(FTA-abs, BioMérieux, France). Direct diagnoses were
made using dark-field microscopy or in-house PCR for
T. pallidum [17]. A swab was taken in the case of ulcer,
with a second swab taken if there were lesions in more
than one site. For typing purposes an extra swab was
taken. Treponemal DNA was detected by means of a
diagnostic real-time PCR (qPCR) and molecular typing
was performed by the Enhanced CDC Typing, analyzing
the arp, tpr and tp0548 genes. This typing is based on
three regions of T. pallidum-2 first described in 1998 by
the Centers for Disease Control and Prevention (CDC)
[18] and extended with tp058 in 2010 by Marra et al.
[10] Participants were offered screening for N. gonor-
rhoeae (NG), C. trachomatis (CT) and HIV, as well as
hepatitis C virus (HCV) in MSM.
Statistical analysis
Categorical variables were expressed as percentages and
comparisons were made using the chi-square test or
Fisher’s exact test, as appropriate. The strength of the
association was measured as the odds ratio (OR) with
95% confidence intervals (95% CI). Continuous variables
were expressed as the mean (+/− SD) or median and
interquartile range [IQR]. Comparisons were performed
using a Student t test, Mann-Whitney U test, ANOVA,
or Kruskal-Walls test with 95% CI if there were more
than two groups. Variables identified as clinically signifi-
cant at the univariate level (p < 0.01) were tested in a
final regression model using the Akaike information
criterion (AIC). The “R” program (R Foundation for
Statistical Computing, Vienna, Austria), version 3.3.1,
was used for all analyses.
Ethical approval was granted by the Hospital Vall
d’Hebron Ethics Committee (PR(AG)297/2014) and all
patients provided written informed consent obtained by
the attending physician.
Results
Among patients diagnosed with early syphilis during the
study period, 33 patients declined to participate while
another 3 were < 18 years old. In total, 270 patients with
274 episodes (4 patients had 2 episodes during this
period) were included. In terms of episodes, 76 (27.7%)
were primary syphilis, 140 (51.1%) were secondary syph-
ilis and 58 (21.2%) were early latent syphilis. Most pa-
tients (257 [95%]) were MSM including bisexuals; there
were 2 (0.75%) women and 11 (4.0%) heterosexual men.
The median age was 36 [30–44] years, 60.5% were au-
tochthonous, 65.0% had university-level education,
73.5% were employed, and 7.0% were students. A total
of 95 (36.0%) patients knew they were HIV-positive at
the time of syphilis diagnosis. Four patients had never
undergone an HIV test (these patients were excluded
from the comparative study). In HIV-positive patients,
the median CD4 count was 653 cells/μl [517–810] and
85 (89.5%) were on antiretroviral therapy (ART). Among
all patients, 42.8% (110) had a previous history of
syphilis.
A total of 266 patients completed the questionnaire
answering more than 85% of the questions (2 cases were
excluded from the behavioral analysis due to incomplete-
ness). Overall, in the past 12months, the median number
of contacts was 10 and CAS was practiced in 72.5% of
cases. Half (50.6%) of them engaged in sex in group and
54.7% used drugs for sex- 25.0% practiced chemsex and
22.6% engaged in poly drug use. Two-thirds of patients
searched for sexual partners through apps and 34.5%
through the internet (Table 1).
Clinically, in primary syphilis, genital chancre was the
most common manifestation in 73.7% (56/76) of cases
followed by anal chancre in 22.4% (17/76). Others loca-
tions (such as oral or urethral) were uncommon, less
than 4% (3/76). All (except 2 cases) were confirmed by
positive dark-field microscopy or PCR positive for T.
pallidum. Oral chancre was found in 2 patients. Notably,
31.1% had more than one chancre and 2 patients had
genital and anal chancres simultaneously. Coexistent
chancres in secondary syphilis were observed in 38
(28.5%) of patients. The most frequent secondary lesions
were syphilides in the genital area (70.7%) and skin rash
(62.1%) affecting the soles (45.0%) more often than the
palms of the hands (40.7%). The most common systemic
manifestations were asthenia (27.1%), sore throat
(22.1%), lymph node enlargement (10.7%), and malaise
(10.7%) (Table 2).
The median RPR titre at diagnosis was 1/32 [1/8; 1/64].
Among patients offered STI screening, 257 (94.0%) of
them received NG and CT / lymphogranuloma venereum
tests, with a prevalence of 9.3 and 16.0%, respectively. HIV
was tested in 148 patients with 8.8% (13/148) being newly
diagnosed while 5 (2.7%) of 189 patients tested positive for
HCV (Table 3).
The majority of patients were treated with benzathine
penicillin G 2.4 million units IM as a single dose (93.0%)
and 14 (5.2%) were treated with oral doxycycline 100 mg
twice daily for 14 days. About a year after treatment, a
four-fold decrease in the non-treponemal test titre was
observed in all but 14 patients (2 patients were rein-
fected, 1 had a serological failure and 11 were missing).
Five patients became HIV-positive and 4 new cases of
HCV occurred during the first year after syphilis diagno-
sis. Furthermore, 14 new syphilis reinfection cases
occurred, 5 of them in HIV-positive patients.
Molecular typing was performed in 78 anogenital ul-
cers samples (16 samples could be typed only partially):
55 were from genital ulcers and 23 from anal ulcers. A
high variety of strains was found making clinical associa-
tions unreliable. The strain type distribution (compared
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Table 1 Risk factors related to early syphilis, overall and by HIV serostatus. Barcelona 2015
HIV negative
N = 167
%
95%CI
HIV positive
N = 95
%
95%CI
ALL
N = 266a
%
p
Value
aOR
(95% CI)
Sexual practices and condomless anal sex
(CAS)
CAS 104 75 183 0.002
65.5 84.3 72.5
(57.4, 72.7) (75.0, 91.1)
Receptive anal sex 107 77 185 0.011
67.3 82.8 72.3
(59.4, 74.5) (73.5, 89.8)
Receptive CAS 40 46 88 0.005
39.6 62.2 49.7
(30.0, 49.8) (50.1, 73.2)
Number of casual partners 10 10 10 0.041
[4-5] [5.75–32.8] [4-20]
Number of casual partners with anal
sex
5 6.5 6 0.039
[2-12] [4–21.5] [2-15]
Number of casual partners with CAS 1 3 1 0.001
[0–2.25] [1-7] [0-4]
Sexual risk behaviors Serosorting 4 28 32 < 0.001 20.4
3 43.1 16 [7.99–
60.96]
(0.8, 7.6) (30.8, 55.9)
Seroposition 10 15 25 0.004
8.4 25.4 13.8
(4.1, 14.9) (14.9, 38.4)
Contact through App 99 65 166 0.164
61 70.7 64.3
(53.1, 68.6) (60.2, 79.7)
Contact through internet 55 34 89 0.729
34 37 34.5
(26.7, 41.8) (27.1, 47.6)
Club sex 27 27 54 0.027
16.7 29.3 20.9
(11.2, 23.3) (20.3, 39.7)
Sauna 33 17 50 0.841
20.4 18.5 19.5
(14.4, 27.4) (11.1, 27.9)
Fisting 28 21 50 0.232
18.1 25.6 20.7
(12.3, 25.0) (16.6, 36.4)
Sex in group 66 59 125 < 0.001
41.8 69.4 50.6
(34.0, 49.8) (58.4, 78.9)
Toys 53 39 93 0.06
33.3 46.4 37.7
(26.0, 41.2) (35.4, 57.6)
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by proportions and graphics) between genital and anal
chancre was similar, with 14d/g isolated most often in
both (12.7% in genital chancre; 30.4% in anal chancre),
followed by 14f/g (9.0% in genital chancre; 17.3% in anal
chancre). In multiple chancres, 14d/g was also most
common (20.0%). One patient with concomitant genital
and anal chancres had different types in anal chancre
(14f/g) compared with genital chancre (−p/g partial
result).
Comparative study by HIV status
All HIV-positive patients were MSM. Compared with
HIV-negative patients, HIV-positive patients were
older (39 [34–44] vs 34[29–43] years, p = 0.01), and
were more likely to have had previous episodes of
NG, CT, and syphilis, as well as HCV coinfection
(Table 4). They also had more anonymous contacts in
the past 12 months (87.0% vs 91%) with a median of
10 [5.75–32.8],3 [1-7]of which were CAS. There was
no difference between the group in insertive anal sex;
however, HIV-positive patients had more receptive
anal sex (82.8% vs. 67.3%; p = 0.011) (Table 1).
Concerning condom use for anal sex, HIV-positive
patients were more likely to practice CAS (84.3%)
than HIV-negative patients (65.5%; p = 0.002).
Remarkably, 43.1% of HIV-positive patients practiced
serosorting and 25.4% practiced seropositioning, while
HIV-negative patients more frequently had CAS after
having been tested for HIV (Table 1). Other risk
factors were also more common in HIV-positive patients,
such as having sex in group (69.4%), use of toys (46.4%),
and drugs for sex (71.0%), mainly involving cocaine, GHB,
mephedrone, sildenafil, and crystal methamphetamine.
Poly drug use was reported by 34 HIV-positive patients
(35.7%) and chemsex by 40 (42.1%). Among HIV-negative
Table 1 Risk factors related to early syphilis, overall and by HIV serostatus. Barcelona 2015 (Continued)
HIV negative
N = 167
%
95%CI
HIV positive
N = 95
%
95%CI
ALL
N = 266a
%
p
Value
aOR
(95% CI)
Drugs for sex 78 66 145 < 0.001
46.7 71 54.7
(38.9, 54.5) (60.6, 79.9)
Cocaine 21 27 49 0.096
26.4 41.5 34
(17.5, 38.1) (29.4, 54.4)
Mephedrone 4 12 16 0.024
5 18.5 11
(1.4, 12.6) (9.9, 30.0)
GHB 22 35 58 0.003
28.2 53.8 40.3
(18.6, 39.5) (41.0, 66.3)
Sildenafil 20 29 49 0.028
25.6 44.6 34
(16.4, 36.8) (32.2, 57.4)
Crystal methamphetamine 9 19 28 0.015
11.5 29.2 19.5
(5.4, 20.7) (18.6, 41.8)
Poly drug use 27 34 61 0.05
16 37 22.6
(10.9, 22.6) (23.2, 46.2)
Chemsex 26 40 67 0.001
15.5 42 25
(10.4, 21.9) (32.0, 52.6)
+in italics: median with interquartile range in brackets
afour cases with HIV unknown serostatus
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patients, 27 (16.1%) reported poly drug use (p = 0.05),
and 26 (15.5%) reported chemsex (p = 0.001). Four pa-
tients, all HIV-positive, reported IV drug use. The
final regression model showed that HIV-positive pa-
tients with syphilis were more likely to have previous
syphilis (adjusted-OR, (ad-OR) 4.81 [2.88–8.15)] and
previous NG infection (ad-OR 3.8 [2.28–6.43)]. Al-
though mainly related with people with HIV, sero-
sorting (ad-OR 20.4 [7.99–60.96)] was strongly
associated with syphilis in HIV-positive patients.
Clinically, in HIV-positive patients, secondary syphilis
was the most common stage (61.9%). Primary syphilis was
seen less often (15.2%), with a similar proportion to early
latent syphilis (22.6%) compared with HIV-negative
patients (early latent syphilis in 20.2%,secondary syphilis in
44.5%, primary in 35%; p = 0.002). After stratifying for pre-
vious syphilis as a possible confounding factor, the differ-
ence was still significant, secondary syphilis occurred more
often in HIV-positive patients without a previous history of
syphilis. Anal chancres were more common in HIV-positive
patients than in HIV-negative patients (41.2% vs. 17.0%;
p = 0.04). In secondary syphilis, there were no signifi-
cant difference between these two groups (Table 2),
even in terms of coexistent chancres. Median RPR ti-
ters were higher in HIV-positive patients at 1/64 [1/
32–1/64] than in HIV-negative patients at 1/16 [1/4–
1/64] p < 0.001 (Table 3). RPR titres stratified by
previous history of syphilis showed that this difference
persisted among patients without a previous history
of syphilis. When RPR titers were stratified by stage
the difference disappeared in secondary syphilis, in
contrast with primary and early latent syphilis where
RPR titers were higher in HIV-positive patients. There
were no differences between the two groups in treat-
ment received, evolution of RPR or cure of syphilis
after 1 year of treatment (p = 0.2).
Table 2 Clinical manifestation of early syphilis. Barcelona 2015
HIV-negative HIV-positiveb All P Value
Primary syphilis
N = 59a
%
N = 17
%
N = 76
%
Genital chancre 46 10 56 0.129
78 58.8 73.7
Anal chancre 10 7 17 0.049
17 41.2 22.4
Multiples chancres 17 6 23 0.553
29.3 37.5 31.1
Secondary syphilis N = 75 N = 65 N = 140
% % %
Skin eruption 51 36 87 0.174
68.0 55.4 62.1
Palm lesion 30 27 57 0.99
40.0 41.5 40.7
Sole lesion 36 27 63 0.551
48.0 41.5 45
Genital syphilides 54 45 99 0.863
72.0 69.2 70.7
Sore throat 16 15 31 0.965
21.3 23.1 22.1
Asthenia 18 20 38 0.479
24.0 30.8 27.1
Malaise 8 7 15 1
10.7 10.8 10.7
Lymph node enlargement 11 4 15 0.1
14.7 6.15 10.7
aincluding 3 other cases with oral and urethral chancres
bincluding patients diagnosed coinciding with syphilis infection
Arando et al. BMC Infectious Diseases          (2019) 19:727 Page 6 of 9
Discussion
In our study the dominant profile of the epidemic
was MSM. Globally in high-income settings, MSM
accounts for a disproportionate burden of syphilis
infections [19]. This study shows that this cohort of
patients with early syphilis, especially HIV-positive
patients, engage in high-risk sexual behaviors. At our
clinic we had previously found an HIV coinfection
rate of 30% in a study conducted between 2003 and
2013 [20]. In this study, we show that this relation-
ship has persisted over time, as we have now found
that 36% of patients with syphilis were HIV-positive
and 8.5% were newly diagnosed concomitantly with
syphilis. HIV and syphilis are related to each other [21,
22], and syphilis itself could increase the risk of HIV infec-
tion [23]. However, this increased risk could also be asso-
ciated with sexual behavior, as HIV-positive patients
engage in more high-risk behaviors than HIV-negative
patients as we report here, similarly to others researches
[24–27]. Factors such as sex in group, multiple sex part-
ners, CAS and use of drugs for sex, could also each raise
the risk of syphilis [3, 7]. However, these factors are mutu-
ally linked, a fact that might increase the probability of
infection. An example of this interrelationship is chemsex,
Table 4 Previous STI related to early syphilis, overall and by HIV serostatus. Barcelona 2015
HIV negative
N = 167
%
(95% CI)
HIV positive
N = 95
%
(95% CI)
All
N = 266a
%
p Value aOR
(95% CI)
Previous STI
Syphilis 42 68 110 < 0.001 4.81
26.4 72.3 42.8 [2.88–8.15]
(19.7, 33.9) (62.1, 81.0)
N. Gonorrhoeae 42 59 101 < 0.001 3.8
26.8 66.3 40 [2.28–6.43]
(20.0, 34.4) (55.5, 75.9)
C. Trachomatis 20 31 51 < 0.001
13.3 38.3 21.5
(8.3, 19.8) (27.7, 49.7)
HCV coinfection 3 13 16 < 0.001
1.8 13.7 6
(0.3, 5.1) (7.5, 22.2)
afour cases with HIV unknown serostatus
Table 3 Microbiological results (RPR and coinfection) of early syphilis. Barcelona 2015
HIV negative HIV positivea All P
ValueN = 168
61.3%
N = 106
38.3%
N = 274
100%
RPR 1/16 1/64 1/32 < 0.001
[1/4–1/64] [1/32–1/64] [1/8;1/64]
STI coinfectionb
Neisseria gonorrhoeae 12 12 24 0.378
7.69 11.9 9.3
Chlamydia trachomatis 24 17 41 0.949
15.4 16.8 15.9
Lymphogranuloma venereum 4 6 10 0.267
18.2 37.5 26.3
Hepatitis C virus 3 2 5 0.637
2.29 3.64 2.67
+in italics: median with interquartile range in brackets
aincluding patients diagnosed coinciding with syphilis infection
bSTI screening done in 257 patients for N. gonorrhoeae and C. trachomatis/L. venerum and 189 patients for hepatitis C
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a growing global phenomenon which has been associated
with a higher number of partners and CAS, situations in
which patients more likely to be diagnosed with acute rec-
tal or bacterial STIs, and HCV [28].
From a clinical perspective, HIV may modify the clin-
ical presentation [22] and course of syphilis. After
adjusting for a previous history of syphilis, we found that
there were still differences in the stage depending on
HIV status, with secondary syphilis being more common
among HIV-positive patients, similar to the findings of
Hutchinson et al. [9] An atypical presentation of syphilis,
such as multiple chancres and concurrent primary chan-
cres in secondary syphilis, had been described more
often in HIV-positive patients [8, 22]. In our study we
found no such differences with the exception that HIV-
positive patients had more anal chancres. This could be
explained by seropositioning, in addition to the fact that
HIV-positive patients practiced receptive anal sex more
often than HIV-negative patients. When taking into ac-
count T. pallidum typing, molecular studies have associ-
ated some strain types with clinical outcomes, such as
neurosyphilis [10], ocular involvement [11], or serofast
status [12]. Following this methodology, we explored
whether or not multiple chancres and other clinical
manifestations of early syphilis could be related to a spe-
cific strain. We found a high diversity of strains in a lim-
ited sample size, precluding any associations. More
refined molecular methods such as multilocus sequence
typing (MLST) or whole genome sequencing could per-
haps be more conclusive [29]. We speculate that HIV
could influence the clinical presentation of syphilis in a
way similar to how immunological factors affect the
manifestation of syphilis in patients with a history of
syphilis [30].
Factors that influence the natural course of an infection
include host susceptibility, bacterial characteristic and
transmissibility, and host immunity [31]. Rekart et al. [32]
suggested that ART could increase the susceptibility to
syphilis due to changes in the innate and adaptive immune
responses to T. pallidum by suppressing mitochondrial
function, proinflammatory response, and macrophage acti-
vation. They concluded that the immunological effects of
ART and ART-induced behavioral changes could act syner-
gistically to increase susceptibility to syphilis. Could this be
the reason why HIV-positive patients are more likely to
have secondary syphilis than HIV-negative patients? In view
of our findings on risk behaviors in HIV-positive patients
compared with HIV-negative patients, we suggest that sex-
ual behavior probably has a much greater effect than other
factors, as Tuddenhem et al. [33] argued.
This study did have several limitations. First, it was car-
ried out at a single center in Barcelona and, therefore, the
findings could not be generalized. Nevertheless, the clinic
is a known referral center attending a large number of
patients with high-risk sexual behaviors and the main
findings are in line with those reported by others else-
where. Another limitation is the use of self-reporting,
sometimes with partial information, an approach that
could have influenced some of the results. Apart from the
inherent constraints of this method, the limited number
of samples for molecular typing made it impossible to
gather relevant information on the clinical manifestations
of syphilis. Further results on microbiological typing in
syphilis obtained in this study will be published elsewhere
(Fernandez-Naval C. et al, submitted). Last, the sample
size is underpowered to make multiple comparisons be-
tween groups but the results are consistent with those of
other studies.
Conclusion
In conclusion, HIV-positive MSM patients are more likely
than HIV-negative patients to have risk factors for syphilis,
such as anonymous contacts, CAS, and chemsex. These
factors facilitate syphilis acquisition and and have been
found to contribute to the syphilis epidemic in Western
countries. HIV-positive patients practicing receptive anal
sex and seropositioning may cause them to have anal chan-
cres more often than HIV-negative patients. HIV could in-
fluence the natural course of syphilis as secondary syphilis
has been found to be more common in HIV-positive pa-
tients. These findings are an updated report on syphilis in
Barcelona and provide important information to be consid-
ered for public health interventions, including STI screen-
ing and, access to health services and risk-reduction
programs targeting high-risk groups.
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